Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CStone Pharmaceuticals Director's Dealing 2022

Jul 19, 2022

50715_rns_2022-07-19_94c60129-20eb-4ee4-9b4e-2040e73f35ef.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [173 x 58] intentionally omitted <==

Public Disclosure Form

19 July 2022

Possible offer

Disclosure of dealings in the shares of Yankuang Energy Group Company Limited

The Executive received the following disclosure of securities dealings pursuant to Rule 22 of the Hong Kong Code on Takeovers and Mergers:

Party Date Descriptionof relevantsecurities Nature of dealings Purchase/ Sale Totalnumber ofsharesinvolved Totalamount paid/ received Highest (H)prices paid/ received Lowest (L)prices paid/ received
China InternationalCapital CorporationLimited 18 July2022 Other typesof securities(e.g. equityswaps) Closing / flattening / unwinding ofproprietary positions arising fromunsolicited client-driven dealings.I confirm this was done no laterthan the close of the morningtrading session on the trading dayfollowing the orginatingclient-driven dealing Purchase 2,000 $48,200.0000 $24.1000 $24.1000

Public Disclosure Form

==> picture [71 x 43] intentionally omitted <==

Other typesof securities(e.g. equityswaps) Closing / flattening / unwinding ofproprietary positions arising fromunsolicited client-driven dealings.I confirm this was done no laterthan the close of the morningtrading session on the trading dayfollowing the orginatingclient-driven dealing Sale 2,000 $48,200.0000 $24.1000 $24.1000

End

Note:

China International Capital Corporation Limited is an exempt principal trader connected with the Offeror. Dealings were made for its own account.